Share Price and Basic Stock Data
Last Updated: January 17, 2026, 12:19 pm
| PEG Ratio | 5.82 |
|---|
Analyst Insight & Comprehensive Analysis
AI Stock Ranker – Real-Time Fundamental Strength Score
Business Overview and Revenue Trends
Prism Johnson Ltd operates in the cement industry and has reported a recent market price of ₹130 with a market capitalization of ₹6,550 Cr. The company has shown a fluctuating revenue trend, with sales recorded at ₹1,663.32 Cr in September 2022, rising to ₹2,111.73 Cr by March 2023. However, sales subsequently declined to ₹1,837.81 Cr in September 2023 before slightly rebounding to ₹1,728.33 Cr in December 2023. For the trailing twelve months (TTM), total sales stood at ₹7,700 Cr, reflecting a modest growth compared to ₹7,361 Cr in the previous fiscal year. The operating profit margin (OPM) for the latest reporting period reached 10.04%, indicating a recovery in profitability after a dip to 5.03% in September 2023. Overall, Prism Johnson’s revenue trajectory demonstrates resilience in a challenging market, although it faces volatility typical of the cement sector, which is often impacted by infrastructure spending and economic cycles.
Profitability and Efficiency Metrics
Prism Johnson’s profitability metrics indicate a mixed performance over recent quarters. The company reported a net profit of ₹163 Cr, translating to a return on equity (ROE) of 4.00%, which is notably low compared to industry standards. The operating profit for the current fiscal year is ₹739 Cr, yielding an operating profit margin of 10.04%. However, the interest coverage ratio (ICR) stood at 2.45x, showcasing a moderate ability to meet interest obligations. Additionally, the company has faced challenges with profitability, as evidenced by the net profit fluctuations, including a loss of ₹11.47 Cr in December 2023. The cash conversion cycle (CCC) remained efficient at 4 days, suggesting effective management of working capital. While Prism Johnson has shown improvements in operational efficiency, the low ROE and fluctuating profit figures highlight ongoing challenges in achieving sustainable profitability.
Balance Sheet Strength and Financial Ratios
Prism Johnson’s balance sheet reflects a cautious financial position with total borrowings reported at ₹1,694 Cr against reserves of ₹958 Cr, resulting in a debt-to-equity ratio of 0.74x. This indicates a manageable level of debt relative to equity, although the company’s total liabilities have risen to ₹7,302 Cr, up from ₹6,547 Cr the previous year. The current ratio is 0.75x, suggesting potential liquidity constraints, while the quick ratio is lower at 0.52x. The company reported a book value per share of ₹29.36 and a price-to-book value (P/BV) of 4.62x, indicating a significant premium in valuation. The return on capital employed (ROCE) was low at 2.22%, which raises concerns about the effectiveness of capital utilization. Overall, while Prism Johnson maintains a reasonable debt level and asset base, the financial ratios suggest limited financial flexibility and pressure on returns.
Shareholding Pattern and Investor Confidence
The shareholding structure of Prism Johnson Ltd indicates a strong promoter backing, with promoters holding 74.87% of the equity. Institutional ownership is relatively low, with Foreign Institutional Investors (FIIs) at 3.47% and Domestic Institutional Investors (DIIs) at 6.08%. Public shareholding accounted for 15.57%, with a total of 78,815 shareholders as of the latest reporting period. Over the past year, there has been a slight increase in DIIs from 4.11% in December 2022 to 6.08% in September 2025, which may suggest growing institutional interest. However, the low level of institutional investment could indicate a lack of confidence among larger investors regarding the company’s growth prospects. The consistent promoter stake reflects stability, but the reliance on retail investors may expose the company to greater volatility in stock performance. Overall, the shareholding pattern highlights strong promoter support but raises questions about broader market confidence.
Outlook, Risks, and Final Insight
Prism Johnson faces a mixed outlook, characterized by both opportunities and risks. On the positive side, the company’s recent revenue recovery and efficient cash conversion cycle indicate potential for growth if the macroeconomic environment remains favorable. However, risks include low profitability metrics, particularly the low ROE of 4.00%, and the high P/E ratio of 87.3, which could deter new investments. Additionally, the fluctuating net profits and rising liabilities pose significant challenges to financial stability. The company’s ability to manage its debt effectively while improving profitability will be crucial. In a scenario where infrastructure spending increases, Prism Johnson could benefit significantly; conversely, any economic downturns or increased competition could adversely affect its performance. Overall, while there are pathways for growth, Prism Johnson must navigate significant financial and operational challenges to enhance shareholder value.
Source: Getaka Fundamental Analysis | Generated using proprietary financial data.
Competitors
| Stock Name ⇩ | Market Cap ⇩ | Current Price ⇩ | High / Low ⇩ | Stock P/E ⇩ | Book Value ⇩ | Dividend Yield ⇩ | ROCE ⇩ | ROE ⇩ | Face Value ⇩ |
|---|---|---|---|---|---|---|---|---|---|
| Bheema Cements Ltd | 52.7 Cr. | 16.2 | 19.5/16.2 | 0.60 | 0.00 % | 13.1 % | 108 % | 10.0 | |
| UltraTech Cement Ltd | 3,64,754 Cr. | 12,378 | 13,102/10,048 | 49.7 | 2,444 | 0.63 % | 10.9 % | 9.29 % | 10.0 |
| The Ramco Cements Ltd | 25,328 Cr. | 1,072 | 1,209/788 | 131 | 322 | 0.19 % | 4.83 % | 1.56 % | 1.00 |
| The India Cements Ltd | 14,830 Cr. | 479 | 486/239 | 325 | 0.00 % | 5.49 % | 8.83 % | 10.0 | |
| Star Cement Ltd | 8,748 Cr. | 216 | 309/197 | 28.9 | 74.4 | 0.46 % | 8.39 % | 6.05 % | 1.00 |
| Industry Average | 38,765.46 Cr | 1,984.58 | 37.49 | 573.47 | 0.54% | 8.79% | 85.81% | 7.13 |
Quarterly Result
| Metric | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 1,663.32 | 1,774.30 | 2,111.73 | 1,942.15 | 1,837.81 | 1,728.33 | 2,065.86 | 1,763.15 | 1,640.40 | 1,820.65 | 2,102.33 | 1,921.75 | 1,855.10 |
| Expenses | 1,630.57 | 1,714.16 | 1,964.54 | 1,790.52 | 1,745.39 | 1,594.74 | 1,954.53 | 1,630.91 | 1,594.27 | 1,768.16 | 1,914.83 | 1,753.34 | 1,668.93 |
| Operating Profit | 32.75 | 60.14 | 147.19 | 151.63 | 92.42 | 133.59 | 111.33 | 132.24 | 46.13 | 52.49 | 187.50 | 168.41 | 186.17 |
| OPM % | 1.97% | 3.39% | 6.97% | 7.81% | 5.03% | 7.73% | 5.39% | 7.50% | 2.81% | 2.88% | 8.92% | 8.76% | 10.04% |
| Other Income | 1.70 | 13.63 | 13.48 | 17.22 | 259.80 | 5.97 | 8.75 | 17.97 | 16.79 | 91.24 | 166.79 | 11.03 | 13.94 |
| Interest | 44.30 | 49.42 | 49.64 | 48.45 | 43.50 | 49.24 | 51.43 | 54.66 | 56.90 | 56.33 | 55.33 | 46.33 | 44.22 |
| Depreciation | 90.14 | 101.34 | 104.54 | 93.06 | 95.17 | 99.29 | 126.28 | 111.57 | 117.75 | 121.11 | 132.99 | 135.68 | 139.68 |
| Profit before tax | -99.99 | -76.99 | 6.49 | 27.34 | 213.55 | -8.97 | -57.63 | -16.02 | -111.73 | -33.71 | 165.97 | -2.57 | 16.21 |
| Tax % | -17.37% | -17.72% | 34.51% | 24.07% | 14.24% | 27.87% | -47.08% | 13.98% | -7.21% | -236.55% | 27.09% | 116.34% | 90.19% |
| Net Profit | -82.62 | -63.35 | 4.25 | 20.76 | 183.14 | -11.47 | -30.50 | -18.26 | -103.67 | 46.03 | 121.01 | -5.56 | 1.59 |
| EPS in Rs | -1.32 | -1.06 | 0.14 | 0.36 | 3.63 | -0.07 | -0.32 | -0.15 | -1.78 | 0.96 | 2.57 | 0.05 | 0.06 |
Last Updated: December 29, 2025, 12:05 pm
Below is a detailed analysis of the quarterly data for Prism Johnson Ltd based on the most recent figures (Sep 2025) and their trends compared to the previous period:
- For Sales, as of Sep 2025, the value is 1,855.10 Cr.. The value appears to be declining and may need further review. It has decreased from 1,921.75 Cr. (Jun 2025) to 1,855.10 Cr., marking a decrease of 66.65 Cr..
- For Expenses, as of Sep 2025, the value is 1,668.93 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 1,753.34 Cr. (Jun 2025) to 1,668.93 Cr., marking a decrease of 84.41 Cr..
- For Operating Profit, as of Sep 2025, the value is 186.17 Cr.. The value appears strong and on an upward trend. It has increased from 168.41 Cr. (Jun 2025) to 186.17 Cr., marking an increase of 17.76 Cr..
- For OPM %, as of Sep 2025, the value is 10.04%. The value appears strong and on an upward trend. It has increased from 8.76% (Jun 2025) to 10.04%, marking an increase of 1.28%.
- For Other Income, as of Sep 2025, the value is 13.94 Cr.. The value appears strong and on an upward trend. It has increased from 11.03 Cr. (Jun 2025) to 13.94 Cr., marking an increase of 2.91 Cr..
- For Interest, as of Sep 2025, the value is 44.22 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 46.33 Cr. (Jun 2025) to 44.22 Cr., marking a decrease of 2.11 Cr..
- For Depreciation, as of Sep 2025, the value is 139.68 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 135.68 Cr. (Jun 2025) to 139.68 Cr., marking an increase of 4.00 Cr..
- For Profit before tax, as of Sep 2025, the value is 16.21 Cr.. The value appears strong and on an upward trend. It has increased from -2.57 Cr. (Jun 2025) to 16.21 Cr., marking an increase of 18.78 Cr..
- For Tax %, as of Sep 2025, the value is 90.19%. The value appears to be improving (decreasing) as expected. It has decreased from 116.34% (Jun 2025) to 90.19%, marking a decrease of 26.15%.
- For Net Profit, as of Sep 2025, the value is 1.59 Cr.. The value appears strong and on an upward trend. It has increased from -5.56 Cr. (Jun 2025) to 1.59 Cr., marking an increase of 7.15 Cr..
- For EPS in Rs, as of Sep 2025, the value is 0.06. The value appears strong and on an upward trend. It has increased from 0.05 (Jun 2025) to 0.06, marking an increase of 0.01.
Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.
Profit & Loss - Annual Report
Last Updated: December 15, 2025, 4:47 am
| Metric | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 5,027 | 5,654 | 5,223 | 5,012 | 5,508 | 6,194 | 5,956 | 5,587 | 6,306 | 7,361 | 7,427 | 7,310 | 7,700 |
| Expenses | 4,840 | 5,293 | 4,873 | 4,651 | 5,057 | 5,586 | 5,409 | 4,958 | 5,829 | 6,987 | 6,930 | 6,885 | 7,105 |
| Operating Profit | 186 | 362 | 350 | 361 | 451 | 609 | 547 | 629 | 478 | 374 | 497 | 425 | 595 |
| OPM % | 4% | 6% | 7% | 7% | 8% | 10% | 9% | 11% | 8% | 5% | 7% | 6% | 8% |
| Other Income | 165 | 92 | 144 | 93 | 67 | 18 | 23 | 37 | 109 | 35 | 292 | 293 | 283 |
| Interest | 280 | 296 | 286 | 221 | 232 | 226 | 258 | 217 | 193 | 197 | 201 | 230 | 202 |
| Depreciation | 200 | 165 | 184 | 192 | 184 | 200 | 251 | 293 | 310 | 390 | 414 | 483 | 529 |
| Profit before tax | -129 | -7 | 24 | 42 | 101 | 201 | 62 | 157 | 84 | -178 | 174 | 5 | 146 |
| Tax % | -34% | -167% | -6% | 66% | 45% | 46% | 119% | 10% | 48% | -11% | 7% | -900% | |
| Net Profit | -85 | 5 | 25 | 14 | 55 | 110 | -12 | 140 | 44 | -158 | 162 | 45 | 163 |
| EPS in Rs | -1.71 | 0.05 | 0.06 | -0.04 | 0.84 | 2.31 | 0.20 | 3.40 | 1.82 | -2.05 | 3.60 | 1.59 | 3.64 |
| Dividend Payout % | 0% | 0% | 0% | 0% | 0% | 22% | 501% | 0% | 0% | 0% | 0% | 0% |
YoY Net Profit Growth
| Year | 2014-2015 | 2015-2016 | 2016-2017 | 2017-2018 | 2018-2019 | 2019-2020 | 2020-2021 | 2021-2022 | 2022-2023 | 2023-2024 | 2024-2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| YoY Net Profit Growth (%) | 105.88% | 400.00% | -44.00% | 292.86% | 100.00% | -110.91% | 1266.67% | -68.57% | -459.09% | 202.53% | -72.22% |
| Change in YoY Net Profit Growth (%) | 0.00% | 294.12% | -444.00% | 336.86% | -192.86% | -210.91% | 1377.58% | -1335.24% | -390.52% | 661.62% | -274.75% |
Prism Johnson Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 11 years from 2014-2015 to 2024-2025.
Growth
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 3% |
| 5 Years: | 4% |
| 3 Years: | 5% |
| TTM: | 2% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| TTM: | 56% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 5% |
| 5 Years: | 24% |
| 3 Years: | 5% |
| 1 Year: | -17% |
| Return on Equity | |
|---|---|
| 10 Years: | 2% |
| 5 Years: | 1% |
| 3 Years: | -5% |
| Last Year: | -4% |
Last Updated: September 5, 2025, 12:40 pm
Balance Sheet
Last Updated: December 4, 2025, 1:50 am
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Sep 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 503 | 503 | 503 | 503 | 503 | 503 | 503 | 503 | 503 | 503 | 503 | 503 | 503 |
| Reserves | 555 | 551 | 495 | 492 | 534 | 623 | 576 | 738 | 820 | 703 | 886 | 975 | 958 |
| Borrowings | 2,104 | 2,236 | 2,212 | 1,980 | 2,020 | 1,918 | 2,425 | 1,930 | 1,744 | 2,182 | 2,243 | 1,978 | 1,694 |
| Other Liabilities | 1,446 | 1,559 | 1,777 | 1,893 | 2,084 | 2,358 | 2,569 | 2,994 | 3,381 | 3,158 | 3,449 | 3,853 | 4,147 |
| Total Liabilities | 4,609 | 4,849 | 4,988 | 4,869 | 5,142 | 5,402 | 6,073 | 6,166 | 6,448 | 6,547 | 7,081 | 7,309 | 7,302 |
| Fixed Assets | 2,474 | 2,413 | 2,472 | 2,415 | 2,602 | 2,626 | 2,821 | 2,946 | 2,970 | 2,947 | 3,260 | 3,285 | 3,238 |
| CWIP | 64 | 72 | 69 | 136 | 100 | 124 | 259 | 132 | 204 | 240 | 141 | 141 | 142 |
| Investments | 226 | 218 | 280 | 339 | 411 | 485 | 523 | 731 | 834 | 911 | 980 | 1,114 | 1,202 |
| Other Assets | 1,846 | 2,147 | 2,166 | 1,978 | 2,030 | 2,167 | 2,470 | 2,357 | 2,439 | 2,449 | 2,699 | 2,769 | 2,720 |
| Total Assets | 4,609 | 4,849 | 4,988 | 4,869 | 5,142 | 5,402 | 6,073 | 6,166 | 6,448 | 6,547 | 7,081 | 7,309 | 7,302 |
Below is a detailed analysis of the balance sheet data for Prism Johnson Ltd based on the most recent figures (Sep 2025) and their trends compared to the previous period:
- For Equity Capital, as of Sep 2025, the value is 503.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 503.00 Cr..
- For Reserves, as of Sep 2025, the value is 958.00 Cr.. The value appears to be declining and may need further review. It has decreased from 975.00 Cr. (Mar 2025) to 958.00 Cr., marking a decrease of 17.00 Cr..
- For Borrowings, as of Sep 2025, the value is 1,694.00 Cr.. The value appears to be improving (decreasing). However, Borrowings exceed Reserves, which may signal higher financial risk. It has decreased from 1,978.00 Cr. (Mar 2025) to 1,694.00 Cr., marking a decrease of 284.00 Cr..
- For Other Liabilities, as of Sep 2025, the value is 4,147.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 3,853.00 Cr. (Mar 2025) to 4,147.00 Cr., marking an increase of 294.00 Cr..
- For Total Liabilities, as of Sep 2025, the value is 7,302.00 Cr.. The value appears to be improving (decreasing). It has decreased from 7,309.00 Cr. (Mar 2025) to 7,302.00 Cr., marking a decrease of 7.00 Cr..
- For Fixed Assets, as of Sep 2025, the value is 3,238.00 Cr.. The value appears to be declining and may need further review. It has decreased from 3,285.00 Cr. (Mar 2025) to 3,238.00 Cr., marking a decrease of 47.00 Cr..
- For CWIP, as of Sep 2025, the value is 142.00 Cr.. The value appears strong and on an upward trend. It has increased from 141.00 Cr. (Mar 2025) to 142.00 Cr., marking an increase of 1.00 Cr..
- For Investments, as of Sep 2025, the value is 1,202.00 Cr.. The value appears strong and on an upward trend. It has increased from 1,114.00 Cr. (Mar 2025) to 1,202.00 Cr., marking an increase of 88.00 Cr..
- For Other Assets, as of Sep 2025, the value is 2,720.00 Cr.. The value appears to be declining and may need further review. It has decreased from 2,769.00 Cr. (Mar 2025) to 2,720.00 Cr., marking a decrease of 49.00 Cr..
- For Total Assets, as of Sep 2025, the value is 7,302.00 Cr.. The value appears to be declining and may need further review. It has decreased from 7,309.00 Cr. (Mar 2025) to 7,302.00 Cr., marking a decrease of 7.00 Cr..
However, the Borrowings (1,694.00 Cr.) are higher than the Reserves (958.00 Cr.), which may signal higher financial risk.
Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.
Cash Flow
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Free Cash Flow
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Free Cash Flow | 184.00 | 360.00 | 348.00 | 360.00 | 449.00 | 608.00 | 545.00 | 628.00 | 477.00 | 372.00 | 495.00 | 424.00 |
Free Cash Flow = Income Generated from Operational Activities - Borrowings - Capital Work in Progress (CWIP)
Consistent positive free cash flow is crucial for businesses as it indicates their ability to generate cash from their core operations. It provides financial flexibility, allowing companies to invest in growth opportunities, pay dividends to shareholders, reduce debt, and weather economic downturns more effectively.
Financial Efficiency Indicators
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 39 | 38 | 43 | 46 | 44 | 43 | 44 | 41 | 36 | 34 | 34 | 42 |
| Inventory Days | 106 | 116 | 119 | 111 | 110 | 131 | 137 | 112 | 142 | 114 | 121 | 121 |
| Days Payable | 133 | 127 | 130 | 141 | 122 | 142 | 143 | 183 | 200 | 146 | 151 | 159 |
| Cash Conversion Cycle | 12 | 26 | 32 | 15 | 32 | 31 | 38 | -29 | -23 | 2 | 3 | 4 |
| Working Capital Days | -24 | -10 | -20 | -46 | -49 | -37 | -49 | -62 | -56 | -70 | -68 | -67 |
| ROCE % | 0% | 7% | 8% | 8% | 10% | 13% | 9% | 11% | 8% | 1% | 3% | 2% |
Mutual Fund Holdings
| Fund Name | No of Shares | AUM (%) | Amount Invested (Cr) | Previous Number of Shares | Previous Date | Percentage Change |
|---|---|---|---|---|---|---|
| SBI ELSS Tax Saver Fund | 20,196,398 | 0.85 | 275.58 | N/A | N/A | N/A |
| SBI Contra Fund | 9,594,645 | 0.26 | 130.92 | 8,598,552 | 2025-12-07 07:40:35 | 11.58% |
| SBI Long Term Advantage Fund - Series V | 390,121 | 1.39 | 5.32 | N/A | N/A | N/A |
Key Financial Ratios
| Month | Mar 25 | Mar 24 | Mar 23 | Mar 22 | Mar 21 |
|---|---|---|---|---|---|
| FaceValue | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 |
| Basic EPS (Rs.) | 1.59 | 3.60 | -2.05 | 1.82 | 3.40 |
| Diluted EPS (Rs.) | 1.59 | 3.60 | -2.05 | 1.82 | 3.40 |
| Cash EPS (Rs.) | 10.13 | 11.15 | 4.42 | 6.89 | 8.51 |
| Book Value[Excl.RevalReserv]/Share (Rs.) | 29.36 | 32.65 | 29.06 | 31.70 | 30.27 |
| Book Value[Incl.RevalReserv]/Share (Rs.) | 29.36 | 32.65 | 29.06 | 31.70 | 30.27 |
| Revenue From Operations / Share (Rs.) | 145.23 | 150.74 | 146.23 | 125.28 | 111.00 |
| PBDIT / Share (Rs.) | 10.86 | 10.40 | 7.85 | 11.18 | 13.11 |
| PBIT / Share (Rs.) | 1.25 | 2.18 | 0.10 | 5.03 | 7.30 |
| PBT / Share (Rs.) | -0.28 | 3.17 | -3.72 | 1.53 | 3.02 |
| Net Profit / Share (Rs.) | 0.52 | 2.93 | -3.33 | 0.73 | 2.70 |
| NP After MI And SOA / Share (Rs.) | 1.59 | 3.60 | -2.05 | 1.82 | 3.40 |
| PBDIT Margin (%) | 7.47 | 6.89 | 5.37 | 8.92 | 11.81 |
| PBIT Margin (%) | 0.86 | 1.44 | 0.07 | 4.01 | 6.57 |
| PBT Margin (%) | -0.19 | 2.10 | -2.54 | 1.22 | 2.72 |
| Net Profit Margin (%) | 0.36 | 1.94 | -2.27 | 0.58 | 2.43 |
| NP After MI And SOA Margin (%) | 1.09 | 2.38 | -1.40 | 1.45 | 3.06 |
| Return on Networth / Equity (%) | 5.40 | 13.03 | -8.55 | 6.93 | 13.79 |
| Return on Capital Employeed (%) | 1.58 | 2.94 | 0.15 | 6.92 | 9.80 |
| Return On Assets (%) | 1.09 | 2.55 | -1.57 | 1.42 | 2.77 |
| Long Term Debt / Equity (X) | 0.59 | 0.66 | 0.79 | 0.88 | 1.15 |
| Total Debt / Equity (X) | 0.74 | 0.95 | 1.22 | 1.18 | 1.25 |
| Asset Turnover Ratio (%) | 1.01 | 1.11 | 1.15 | 0.99 | 0.91 |
| Current Ratio (X) | 0.75 | 0.78 | 0.69 | 0.79 | 0.90 |
| Quick Ratio (X) | 0.52 | 0.54 | 0.46 | 0.51 | 0.66 |
| Inventory Turnover Ratio (X) | 9.14 | 4.27 | 4.01 | 3.62 | 2.96 |
| Interest Coverage Ratio (X) | 2.45 | 2.72 | 2.13 | 3.04 | 3.14 |
| Interest Coverage Ratio (Post Tax) (X) | 0.46 | 0.50 | 0.13 | 1.15 | 1.67 |
| Enterprise Value (Cr.) | 7743.12 | 10071.70 | 6699.86 | 7269.64 | 7896.53 |
| EV / Net Operating Revenue (X) | 1.06 | 1.33 | 0.91 | 1.15 | 1.41 |
| EV / EBITDA (X) | 14.17 | 19.24 | 16.95 | 12.92 | 11.96 |
| MarketCap / Net Operating Revenue (X) | 0.93 | 1.18 | 0.72 | 0.92 | 1.18 |
| Price / BV (X) | 4.62 | 6.47 | 4.39 | 4.39 | 5.33 |
| Price / Net Operating Revenue (X) | 0.93 | 1.18 | 0.72 | 0.92 | 1.18 |
| EarningsYield | 0.01 | 0.02 | -0.01 | 0.01 | 0.02 |
After reviewing the key financial ratios for Prism Johnson Ltd, here is a detailed analysis based on the latest available data and recent trends:
- For FaceValue, as of Mar 25, the value is 10.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 10.00.
- For Basic EPS (Rs.), as of Mar 25, the value is 1.59. This value is below the healthy minimum of 5. It has decreased from 3.60 (Mar 24) to 1.59, marking a decrease of 2.01.
- For Diluted EPS (Rs.), as of Mar 25, the value is 1.59. This value is below the healthy minimum of 5. It has decreased from 3.60 (Mar 24) to 1.59, marking a decrease of 2.01.
- For Cash EPS (Rs.), as of Mar 25, the value is 10.13. This value is within the healthy range. It has decreased from 11.15 (Mar 24) to 10.13, marking a decrease of 1.02.
- For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 29.36. It has decreased from 32.65 (Mar 24) to 29.36, marking a decrease of 3.29.
- For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 29.36. It has decreased from 32.65 (Mar 24) to 29.36, marking a decrease of 3.29.
- For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 145.23. It has decreased from 150.74 (Mar 24) to 145.23, marking a decrease of 5.51.
- For PBDIT / Share (Rs.), as of Mar 25, the value is 10.86. This value is within the healthy range. It has increased from 10.40 (Mar 24) to 10.86, marking an increase of 0.46.
- For PBIT / Share (Rs.), as of Mar 25, the value is 1.25. This value is within the healthy range. It has decreased from 2.18 (Mar 24) to 1.25, marking a decrease of 0.93.
- For PBT / Share (Rs.), as of Mar 25, the value is -0.28. This value is below the healthy minimum of 0. It has decreased from 3.17 (Mar 24) to -0.28, marking a decrease of 3.45.
- For Net Profit / Share (Rs.), as of Mar 25, the value is 0.52. This value is below the healthy minimum of 2. It has decreased from 2.93 (Mar 24) to 0.52, marking a decrease of 2.41.
- For NP After MI And SOA / Share (Rs.), as of Mar 25, the value is 1.59. This value is below the healthy minimum of 2. It has decreased from 3.60 (Mar 24) to 1.59, marking a decrease of 2.01.
- For PBDIT Margin (%), as of Mar 25, the value is 7.47. This value is below the healthy minimum of 10. It has increased from 6.89 (Mar 24) to 7.47, marking an increase of 0.58.
- For PBIT Margin (%), as of Mar 25, the value is 0.86. This value is below the healthy minimum of 10. It has decreased from 1.44 (Mar 24) to 0.86, marking a decrease of 0.58.
- For PBT Margin (%), as of Mar 25, the value is -0.19. This value is below the healthy minimum of 10. It has decreased from 2.10 (Mar 24) to -0.19, marking a decrease of 2.29.
- For Net Profit Margin (%), as of Mar 25, the value is 0.36. This value is below the healthy minimum of 5. It has decreased from 1.94 (Mar 24) to 0.36, marking a decrease of 1.58.
- For NP After MI And SOA Margin (%), as of Mar 25, the value is 1.09. This value is below the healthy minimum of 8. It has decreased from 2.38 (Mar 24) to 1.09, marking a decrease of 1.29.
- For Return on Networth / Equity (%), as of Mar 25, the value is 5.40. This value is below the healthy minimum of 15. It has decreased from 13.03 (Mar 24) to 5.40, marking a decrease of 7.63.
- For Return on Capital Employeed (%), as of Mar 25, the value is 1.58. This value is below the healthy minimum of 10. It has decreased from 2.94 (Mar 24) to 1.58, marking a decrease of 1.36.
- For Return On Assets (%), as of Mar 25, the value is 1.09. This value is below the healthy minimum of 5. It has decreased from 2.55 (Mar 24) to 1.09, marking a decrease of 1.46.
- For Long Term Debt / Equity (X), as of Mar 25, the value is 0.59. This value is within the healthy range. It has decreased from 0.66 (Mar 24) to 0.59, marking a decrease of 0.07.
- For Total Debt / Equity (X), as of Mar 25, the value is 0.74. This value is within the healthy range. It has decreased from 0.95 (Mar 24) to 0.74, marking a decrease of 0.21.
- For Asset Turnover Ratio (%), as of Mar 25, the value is 1.01. It has decreased from 1.11 (Mar 24) to 1.01, marking a decrease of 0.10.
- For Current Ratio (X), as of Mar 25, the value is 0.75. This value is below the healthy minimum of 1.5. It has decreased from 0.78 (Mar 24) to 0.75, marking a decrease of 0.03.
- For Quick Ratio (X), as of Mar 25, the value is 0.52. This value is below the healthy minimum of 1. It has decreased from 0.54 (Mar 24) to 0.52, marking a decrease of 0.02.
- For Inventory Turnover Ratio (X), as of Mar 25, the value is 9.14. This value exceeds the healthy maximum of 8. It has increased from 4.27 (Mar 24) to 9.14, marking an increase of 4.87.
- For Interest Coverage Ratio (X), as of Mar 25, the value is 2.45. This value is below the healthy minimum of 3. It has decreased from 2.72 (Mar 24) to 2.45, marking a decrease of 0.27.
- For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is 0.46. This value is below the healthy minimum of 3. It has decreased from 0.50 (Mar 24) to 0.46, marking a decrease of 0.04.
- For Enterprise Value (Cr.), as of Mar 25, the value is 7,743.12. It has decreased from 10,071.70 (Mar 24) to 7,743.12, marking a decrease of 2,328.58.
- For EV / Net Operating Revenue (X), as of Mar 25, the value is 1.06. This value is within the healthy range. It has decreased from 1.33 (Mar 24) to 1.06, marking a decrease of 0.27.
- For EV / EBITDA (X), as of Mar 25, the value is 14.17. This value is within the healthy range. It has decreased from 19.24 (Mar 24) to 14.17, marking a decrease of 5.07.
- For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 0.93. This value is below the healthy minimum of 1. It has decreased from 1.18 (Mar 24) to 0.93, marking a decrease of 0.25.
- For Price / BV (X), as of Mar 25, the value is 4.62. This value exceeds the healthy maximum of 3. It has decreased from 6.47 (Mar 24) to 4.62, marking a decrease of 1.85.
- For Price / Net Operating Revenue (X), as of Mar 25, the value is 0.93. This value is below the healthy minimum of 1. It has decreased from 1.18 (Mar 24) to 0.93, marking a decrease of 0.25.
- For EarningsYield, as of Mar 25, the value is 0.01. This value is below the healthy minimum of 5. It has decreased from 0.02 (Mar 24) to 0.01, marking a decrease of 0.01.
Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.
Strength and Weakness
| Strength | Weakness |
|---|---|
|
|
Stock Analysis
- Considering all of the following key financial indicators, prospective investors are encouraged to conduct thorough research and seek professional guidance before considering any investment in Prism Johnson Ltd:
- Net Profit Margin: 0.36%
- Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
- ROCE: 1.58% (Industry Average ROCE: 8.79%)
- ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
- ROE%: 5.4% (Industry Average ROE: 85.81%)
- ROE (Return on Equity): ROE measures a company's profitability relative to shareholders' equity. A higher ROE indicates efficient use of shareholders' funds.
- Interest Coverage Ratio (Post Tax): 0.46
- Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
- Quick Ratio: 0.52
- Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
- Stock P/E: 86.6 (Industry average Stock P/E: 37.49)
- Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
- Total Debt / Equity: 0.74
- Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
Stock Rating: - Net Profit Margin: 0.36%
About the Company - Qualitative Analysis
| INDUSTRY | ADDRESS | CONTACT |
|---|---|---|
| Cement | 305, Laxmi Niwas Apartments, Hyderabad Telangana 500016 | Contact not found |
| Management | |
|---|---|
| Name | Position Held |
| Dr. Raveendra Chittoor | Chairman & Ind.Director |
| Mr. Vijay Aggarwal | Managing Director |
| Mr. Raakesh Jain | Executive Director & CEO |
| Mr. Sarat Chandak | Executive Director & CEO |
| Mr. Joseph Conrad Agnelo D'Souza | Independent Director |
| Ms. Ravina Rajpal | Independent Director |
| Mr. Rajan B Raheja | Director |
| Mr. Akshay R Raheja | Director |
FAQ
What is the intrinsic value of Prism Johnson Ltd?
Prism Johnson Ltd's intrinsic value (as of 18 January 2026) is ₹94.16 which is 27.01% lower the current market price of ₹129.00, indicating overvalued. Calculated using the PE ratio method, this valuation considers the company's ₹6,493 Cr. market cap, FY2025-2026 high/low of ₹176/105, reserves of ₹958 Cr, and liabilities of ₹7,302 Cr.
What is the Market Cap of Prism Johnson Ltd?
The Market Cap of Prism Johnson Ltd is 6,493 Cr..
What is the current Stock Price of Prism Johnson Ltd as on 18 January 2026?
The current stock price of Prism Johnson Ltd as on 18 January 2026 is ₹129.
What is the High / Low of Prism Johnson Ltd stocks in FY 2025-2026?
In FY 2025-2026, the High / Low of Prism Johnson Ltd stocks is ₹176/105.
What is the Stock P/E of Prism Johnson Ltd?
The Stock P/E of Prism Johnson Ltd is 86.6.
What is the Book Value of Prism Johnson Ltd?
The Book Value of Prism Johnson Ltd is 29.0.
What is the Dividend Yield of Prism Johnson Ltd?
The Dividend Yield of Prism Johnson Ltd is 0.00 %.
What is the ROCE of Prism Johnson Ltd?
The ROCE of Prism Johnson Ltd is 2.22 %.
What is the ROE of Prism Johnson Ltd?
The ROE of Prism Johnson Ltd is 4.00 %.
What is the Face Value of Prism Johnson Ltd?
The Face Value of Prism Johnson Ltd is 10.0.